Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product

Biochemical Pharmacology

Volumn 70, Issue 7, 2005, Pages 1019-1025

  Lu, Haiqin ^a   Zhu, Jie ^a   Zang, Yuhui ^a   Ze, Yuguan ^a   Qin, Junchuan ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Baculovirus mediated expression system; Dihydrocoumarin; Gene expression; Human paraoxonase 3; LDL oxidation; Sf9 cell

Indexed keywords

ARYLDIALKYLPHOSPHATASE; COMPLEMENTARY DNA; COUMARIN; LOW DENSITY LIPOPROTEIN; PHENYLACETIC ACID; RECOMBINANT ENZYME; VIRUS VECTOR;

ANTIOXIDANT ACTIVITY; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG INHIBITION; ENZYME KINETICS; FETUS; FETUS LIVER; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INSECT CELL; LIPID PEROXIDATION; MOLECULAR CLONING; PRIORITY JOURNAL;

ANIMALS; BACULOVIRIDAE; BASE SEQUENCE; CARBOXYLIC ESTER HYDROLASES; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTERASES; HUMANS; KINETICS; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SPODOPTERA;

EID: 24344477569     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.07.004     Document Type: Article

References (19)

1. S.L. Primo-Parmo, R.C. Sorenson, J. Teiber, and B.N. La Du The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family Genomics 33 1996 498 507
2. S.T. Reddy, D.J. Wadleigh, V. Grijalva, C. Ng, S. Hama, and A. Gangopadhyay Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids Arterioscl Thromb Vas 21 2001 542 547
3. M. Aviram, and M. Rosenblat Paraoxonase1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development Free Radical Bio Med 37 9 2004 1304 1316
4. D.I. Draganov, P.L. Stetson, C.E. Watson, S.S. Billecke, and B.N. La Du Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation J Biol Chem 275 2000 33435 33442
5. B.N. La Du Is paraoxonase-3 another HDL-associated protein protective against atherosclerosis? Arterioscl Thromb Vas 21 2001 467 468
6. M.I. Mackness, S. Arrol, and P.N. Durrington Paraoxonase prevents accumulation of lipoperoxides in low-density-lipoprotein FEBS Lett 286 1991 152 154
7. M. Harel, A. Aharoni, L. Gaidukov, B. Brumshtein, O. Khersonsky, and R. Meged Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes Nat Struct Mol Biol 11 2004 412 419
8. R.W. James, I.L. Eviev, J. Ruiz, P. Passa, P. Froguel, and M.C. Garin Promoter polymorphism T (-107) C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients Diabetes 49 2000 1390 1393
9. D.M. Shih, Y.R. Xia, X.P. Wang, E. Miller, L.W. Castellani, and G. Subbanagounder Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J Biol Chem 275 2000 17527 17535
10. M.N. Oda, J.K. Bielicki, T.T. Ho, T. Berger, E.M. Rubin, and T.M. Forte Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins Biochem Biophys Res Commun 290 2002 921 927
11. A. Tward, Y.R. Xia, X.P. Wang, Y.S. Shi, C. Park, and L.W. Castellani Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice Circulation 106 2002 484 490
12. M.I. Mackness, S. Arrol, C. Abbott, and P.N. Durrington Protection of low-density lipoprotein against oxidative modification by highdensity lipoprotein associated paraoxonase Atherosclerosis 104 1993 129 135
13. M.I. Mackness, B. Mackness, S. Arrol, W. Turkie, and P.N. Durrington Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification FEBS Lett 423 1998 57 60
14. D.I. Draganov, J.F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B.N. La Du Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities J Lipid Res 46 2005 1239 1247
15. M. Aviram, S. Billecke, R. Sorenson, C. Bisgaier, R. Newton, and M. Rosenblat Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R Arterioscl Thromb Vas 18 1998 1617 1624
16. D. Josse, C. Ebel, D. Stroebel, A. Fontaine, F. Borges, and A. Echalier Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1) J Biol Chem 277 2002 33386 33397
17. R.J. Brushia, T.M. Forte, M.N. Oda, B.N. La Du, and J.K. Bielicki Baculovirus-mediated expression and purification of human serum paraoxonase 1A J Lipid Res 42 2001 951 958
18. C.K. Glass, and J.L. Witztum Athrosclerosis: the road ahead Cell 104 2001 503 516
19. J.F. Teiber, D.I. Draganov, and B.N. La Du Serum PON1 does not protect LDL against oxidation induced by copper and AAPH in vitro J Lipid Res 45 2004 2260 2268